HHS submitted a suggestion to the DEA concerning marijuana policy, a move that Senate leaders praised as an initial stride towards relaxing federal constraints on the substance.
According to the DEA, Schedule I drugs"have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse."
Schedule III drugs"have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence." They currently include ketamine and some anabolic steroids.requested the review in October 2022 as he pardoned thousands of Americans convicted of"simple possession" of marijuana under federal law.
Senate Finance Committee Chairman Ron Wyden, D-Ore., issued a statement calling for marijuana to be completely descheduled."However, the recommendation of HHS to reschedule cannabis as a Schedule III drug is not inconsequential," he added."If HHS’s recommendation is ultimately implemented, it will be a historic step for a nation whose cannabis policies have been out of touch with reality."In reaction to the Bloomberg report, the nonprofit U.S.
Get all the stories you need-to-know from the most powerful name in news delivered first thing every morning to your inbox
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
HHS calls on DEA to reclassify marijuana as a lower-risk drugThe DEA defines a Schedule III substance as a drug “with a moderate to low potential for physical and psychological dependence.”
Les mer »
Biden HHS calls for reclassifying marijuana as a lower-risk drugAssistant Secretary for Health Rachel Levine asked Drug Enforcement Administration Administrator Anne Milgram to reclassify marijuana as a lower-risk drug, a move that would have major implications for the legal status of the popular drug nationwide.
Les mer »
HHS calls to move marijuana to lower-risk US drug categoryThe U.S. Department of Health and Human Services (HHS) has recommended easing restrictions on marijuana, Bloomberg News reported on Wednesday, citing a letter.
Les mer »
Biden HHS urges marijuana to be reclassified as legal drug: reportThe Department of Health and Human Services is recommending that marijuana be reranked as a less-dangerous and legal Schedule III drug.
Les mer »
HHS calls for easing restrictions on marijuana, sending cannabis stocks higherThat move could potentially expand the market for cannabis, sending shares of Canopy Growth, Tilray Brands and Cronos Group higher.
Les mer »